119 related articles for article (PubMed ID: 3491205)
1. Cluster differentiation antigen expression, proliferative activity and clinical stage in centroblastic centrocytic lymphomas.
Williamson JM; Grigor I; Smith ME; Holgate CS; Quirke P; Bird CC; Alison DL; Child JA
J Pathol; 1986 Sep; 150(1):51-9. PubMed ID: 3491205
[TBL] [Abstract][Full Text] [Related]
2. Mantle-zone lymphoma. A pattern produced by lymphomas of more than one cell type.
Harris NL; Bhan AK
Am J Surg Pathol; 1985 Dec; 9(12):872-82. PubMed ID: 2933967
[TBL] [Abstract][Full Text] [Related]
3. Centrocytic lymphoma: a distinct clinicopathologic and immunologic entity. A multiparameter study of 18 cases at diagnosis and relapse.
Swerdlow SH; Habeshaw JA; Murray LJ; Dhaliwal HS; Lister TA; Stansfeld AG
Am J Pathol; 1983 Nov; 113(2):181-97. PubMed ID: 6416075
[TBL] [Abstract][Full Text] [Related]
4. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
5. Expression of Leu-8 surface antigen in B-cell lymphomas. Correlation with other B-cell markers.
Carbone A; Manconi R; Poletti A; Gloghini A; De Paoli P; Volpe R
J Pathol; 1988 Feb; 154(2):133-40. PubMed ID: 3258374
[TBL] [Abstract][Full Text] [Related]
6. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
[TBL] [Abstract][Full Text] [Related]
7. Centroblastic and centroblastic/centrocytic lymphoma associated with a prominent epithelioid granulomatous response: a clinicopathologic study of 50 cases.
Kojima M; Nakamura S; Ichimura K; Suzuki R; Kagami Y; Kondo E; Motoori T; Hosomura Y; Oyama T; Itoh H; Ban S; Yoshida K; Ohno Y; Shimizu K; Masawa N; Sugihara S
Mod Pathol; 2002 Jul; 15(7):750-8. PubMed ID: 12118113
[TBL] [Abstract][Full Text] [Related]
8. Two new monoclonal antibodies (LN-1, LN-2) reactive in B5 formalin-fixed, paraffin-embedded tissues with follicular center and mantle zone human B lymphocytes and derived tumors.
Epstein AL; Marder RJ; Winter JN; Fox RI
J Immunol; 1984 Aug; 133(2):1028-36. PubMed ID: 6376628
[TBL] [Abstract][Full Text] [Related]
9. [Immunologic phenotypes of germinal center cell tumors].
Radaszkiewicz T; Majdic O; Hanak H; Knapp W
Wien Klin Wochenschr; 1985 Feb; 97(3):126-30. PubMed ID: 2984848
[TBL] [Abstract][Full Text] [Related]
10. B- and T-cell subsets in follicular centroblastic/centrocytic (cleaved follicular center cell) lymphoma: an immunohistologic analysis of 26 lymph nodes and three spleens.
Swerdlow SH; Murray LJ; Habeshaw JA; Stansfeld AG
Hum Pathol; 1985 Apr; 16(4):339-52. PubMed ID: 2579888
[TBL] [Abstract][Full Text] [Related]
11. [Immunoperoxidase study of normal and pathologic lymphoid tissue. Value of monoclonal antibodies].
Delsol G; Al Saati T; Caveriviere P; Voigt JJ; Ancelin E; Rigal-Huguet F
Ann Pathol; 1984; 4(3):165-83. PubMed ID: 6383412
[TBL] [Abstract][Full Text] [Related]
12. CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles.
Almasri NM; Iturraspe JA; Braylan RC
Arch Pathol Lab Med; 1998 Jun; 122(6):539-44. PubMed ID: 9625422
[TBL] [Abstract][Full Text] [Related]
13. A new monoclonal antibody (KB61) recognizing a novel antigen which is selectively expressed on a subpopulation of human B lymphocytes.
Pulford K; Ralfkiaer E; MacDonald SM; Erber WN; Falini B; Gatter KC; Mason DY
Immunology; 1986 Jan; 57(1):71-6. PubMed ID: 3484721
[TBL] [Abstract][Full Text] [Related]
14. Immunohistologic characterization of two malignant lymphomas of germinal center type (centroblastic/centrocytic and centrocytic) with monoclonal antibodies. Follicular and diffuse lymphomas of small-cleaved-cell type are related but distinct entities.
Harris NL; Nadler LM; Bhan AK
Am J Pathol; 1984 Nov; 117(2):262-72. PubMed ID: 6437232
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous B-cell lymphoma.
Burg G; Kaudewitz P; Klepzig K; Przybilla B; Braun-Falco O
Dermatol Clin; 1985 Oct; 3(4):689-704. PubMed ID: 3916175
[TBL] [Abstract][Full Text] [Related]
16. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
Carbone A; Gloghini A; Gruss HJ; Pinto A
Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
[TBL] [Abstract][Full Text] [Related]
17. Surface membrane phenotypic expression and treatment response of malignant lymphomas.
Lauder I; Bird CC; Child JA; Grigor I
J Pathol; 1985 Mar; 145(3):259-68. PubMed ID: 3920370
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody studies in B(non-T)-cell malignancies.
Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
[TBL] [Abstract][Full Text] [Related]
19. Estimation of silver-binding nucleolar organizer regions (AgNORs) in lymphoproliferative disorders of gastrointestinal tract.
Takahashi H; Fujita S; Okabe H; Tsuda N; Tezuka F
Pathol Res Pract; 1994 Apr; 190(4):350-61. PubMed ID: 8078804
[TBL] [Abstract][Full Text] [Related]
20. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
